Moreover, substantial evidence shows that Met can exert its effects by inhibiting the expression of SOX4, thereby inhibiting the progression of diseases such as breast cancer, lung cancer, and atherosclerosis [30, 68, 69]. This evidence concerns the gene SOX4 and breast cancer.